A credible corporate presence carrying the science and team even without a commercial product, precise pipeline presentation, and a platform sized to what a small team can actually maintain — not an enterprise-scale build the company will grow into eventually.
At Series A, the site is often the primary evidence an investor or partner has before a meeting, and it has to carry the case for the science and team on its own. See biotech for how that credibility gets built without overstating what is actually known.
A Series A team is typically small, and an enterprise-scale platform can add maintenance overhead beyond its available capacity. See mid-size pharma for the broader principle of scoping to actual team capacity, which applies here too.
The platform should be architected to extend through subsequent funding rounds without a full rebuild each time — see pipeline page for one of the components that typically needs to scale as the company progresses.
Usually not the full formal structure yet — a Series A company rarely needs disclosure controls or governance documentation built for public shareholders. What is useful earlier is a simple, credible page summarising funding and leadership, built on a foundation that can expand later without a rebuild. See website before IPO for when the fuller structure becomes necessary.
At Series A, the pipeline page typically covers the lead asset and one or two next candidates, with an honest indication of development stage rather than an exhaustive roadmap. Overstating maturity here is a common early mistake that investors and partners notice quickly. See what goes on a biotech pipeline page for the full structure.
Spend proportionate to team size and immediate need rather than the scale of a future public company. A focused, well-built site covering science, team, and pipeline typically serves a Series A company well; an enterprise-scale build with extensive platform infrastructure is rarely the right investment yet, and that budget is better held for when it is needed.
Yes, expect a meaningful update rather than a full rebuild — by Series B, most companies have more pipeline data, partnership news, and team growth to show, and the site should reflect that progress credibly. Plan the Series A build with this next step in mind so extending it later is straightforward rather than a rework from scratch.
Tell us your stage and team size and we will tell you what is actually worth building now.